Hypofractionated Regional Nodal Irradiation for Women With Node-Positive Breast Cancer.
Identifieur interne : 000510 ( Main/Exploration ); précédent : 000509; suivant : 000511Hypofractionated Regional Nodal Irradiation for Women With Node-Positive Breast Cancer.
Auteurs : Sara Bellefqih [Maroc] ; Sanaa Elmajjaoui [Maroc] ; Jihan Aarab [Maroc] ; Jihane Khalil [Maroc] ; Mohamed Afif [Maroc] ; Amine Lachgar [Maroc] ; Hanan El Kacemi [Maroc] ; Tayeb Kebdani [Maroc] ; Noureddine Benjaafar [Maroc]Source :
- International journal of radiation oncology, biology, physics [ 1879-355X ] ; 2017.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Antinéoplasiques (usage thérapeutique), Antinéoplasiques hormonaux (usage thérapeutique), Facteurs temps, Femelle, Humains, Hyperpigmentation (étiologie), Hypofractionnement de dose, Irradiation ganglionnaire (), Irradiation ganglionnaire (effets indésirables), Mastectomie partielle, Métastase lymphatique, Pronostic, Récepteur ErbB-2 (antagonistes et inhibiteurs), Récidive tumorale locale, Région mammaire, Sujet âgé, Sujet âgé de 80 ans ou plus, Survie sans rechute, Thorax, Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Tumeurs du sein (radiothérapie), Télangiectasie (étiologie), Études de suivi, Études rétrospectives.
- MESH :
- anatomopathologie : Tumeurs du sein.
- antagonistes et inhibiteurs : Récepteur ErbB-2.
- effets indésirables : Irradiation ganglionnaire.
- radiothérapie : Tumeurs du sein.
- usage thérapeutique : Antinéoplasiques, Antinéoplasiques hormonaux.
- étiologie : Hyperpigmentation, Télangiectasie.
- Adulte, Adulte d'âge moyen, Facteurs temps, Femelle, Humains, Hypofractionnement de dose, Irradiation ganglionnaire, Mastectomie partielle, Métastase lymphatique, Pronostic, Récidive tumorale locale, Région mammaire, Sujet âgé, Sujet âgé de 80 ans ou plus, Survie sans rechute, Thorax, Tumeurs du sein, Études de suivi, Études rétrospectives.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Antineoplastic Agents (therapeutic use), Antineoplastic Agents, Hormonal (therapeutic use), Breast, Breast Neoplasms (pathology), Breast Neoplasms (radiotherapy), Breast Neoplasms (surgery), Disease-Free Survival, Dose Hypofractionation, Female, Follow-Up Studies, Humans, Hyperpigmentation (etiology), Lymphatic Irradiation (adverse effects), Lymphatic Irradiation (methods), Lymphatic Metastasis, Mastectomy, Segmental, Middle Aged, Neoplasm Recurrence, Local, Prognosis, Receptor, ErbB-2 (antagonists & inhibitors), Retrospective Studies, Telangiectasis (etiology), Thorax, Time Factors.
- MESH :
- chemical , antagonists & inhibitors : Receptor, ErbB-2.
- chemical , therapeutic use : Antineoplastic Agents, Antineoplastic Agents, Hormonal.
- adverse effects : Lymphatic Irradiation.
- etiology : Hyperpigmentation, Telangiectasis.
- methods : Lymphatic Irradiation.
- pathology : Breast Neoplasms.
- radiotherapy : Breast Neoplasms.
- surgery : Breast Neoplasms.
- Adult, Aged, Aged, 80 and over, Breast, Disease-Free Survival, Dose Hypofractionation, Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Mastectomy, Segmental, Middle Aged, Neoplasm Recurrence, Local, Prognosis, Retrospective Studies, Thorax, Time Factors.
Abstract
To evaluate the effect of hypofractionated radiation therapy (HFRT) of the breast/chest wall and regional nodes on overall survival (OS), disease-free survival (DFS), locoregional control and on treatment-related toxicity in patients with breast cancer and nodal involvement.
DOI: 10.1016/j.ijrobp.2016.11.010
PubMed: 28126305
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000398
- to stream PubMed, to step Curation: 000398
- to stream PubMed, to step Checkpoint: 000398
- to stream Ncbi, to step Merge: 008C57
- to stream Ncbi, to step Curation: 008C57
- to stream Ncbi, to step Checkpoint: 008C57
- to stream Main, to step Merge: 000510
- to stream Main, to step Curation: 000510
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hypofractionated Regional Nodal Irradiation for Women With Node-Positive Breast Cancer.</title><author><name sortKey="Bellefqih, Sara" sort="Bellefqih, Sara" uniqKey="Bellefqih S" first="Sara" last="Bellefqih">Sara Bellefqih</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco. Electronic address: sara.bellefqih@gmail.com.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Elmajjaoui, Sanaa" sort="Elmajjaoui, Sanaa" uniqKey="Elmajjaoui S" first="Sanaa" last="Elmajjaoui">Sanaa Elmajjaoui</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Aarab, Jihan" sort="Aarab, Jihan" uniqKey="Aarab J" first="Jihan" last="Aarab">Jihan Aarab</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Khalil, Jihane" sort="Khalil, Jihane" uniqKey="Khalil J" first="Jihane" last="Khalil">Jihane Khalil</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Afif, Mohamed" sort="Afif, Mohamed" uniqKey="Afif M" first="Mohamed" last="Afif">Mohamed Afif</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Lachgar, Amine" sort="Lachgar, Amine" uniqKey="Lachgar A" first="Amine" last="Lachgar">Amine Lachgar</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="El Kacemi, Hanan" sort="El Kacemi, Hanan" uniqKey="El Kacemi H" first="Hanan" last="El Kacemi">Hanan El Kacemi</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Kebdani, Tayeb" sort="Kebdani, Tayeb" uniqKey="Kebdani T" first="Tayeb" last="Kebdani">Tayeb Kebdani</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Benjaafar, Noureddine" sort="Benjaafar, Noureddine" uniqKey="Benjaafar N" first="Noureddine" last="Benjaafar">Noureddine Benjaafar</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28126305</idno><idno type="pmid">28126305</idno><idno type="doi">10.1016/j.ijrobp.2016.11.010</idno><idno type="wicri:Area/PubMed/Corpus">000398</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000398</idno><idno type="wicri:Area/PubMed/Curation">000398</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000398</idno><idno type="wicri:Area/PubMed/Checkpoint">000398</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000398</idno><idno type="wicri:Area/Ncbi/Merge">008C57</idno><idno type="wicri:Area/Ncbi/Curation">008C57</idno><idno type="wicri:Area/Ncbi/Checkpoint">008C57</idno><idno type="wicri:Area/Main/Merge">000510</idno><idno type="wicri:Area/Main/Curation">000510</idno><idno type="wicri:Area/Main/Exploration">000510</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Hypofractionated Regional Nodal Irradiation for Women With Node-Positive Breast Cancer.</title><author><name sortKey="Bellefqih, Sara" sort="Bellefqih, Sara" uniqKey="Bellefqih S" first="Sara" last="Bellefqih">Sara Bellefqih</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco. Electronic address: sara.bellefqih@gmail.com.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Elmajjaoui, Sanaa" sort="Elmajjaoui, Sanaa" uniqKey="Elmajjaoui S" first="Sanaa" last="Elmajjaoui">Sanaa Elmajjaoui</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Aarab, Jihan" sort="Aarab, Jihan" uniqKey="Aarab J" first="Jihan" last="Aarab">Jihan Aarab</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Khalil, Jihane" sort="Khalil, Jihane" uniqKey="Khalil J" first="Jihane" last="Khalil">Jihane Khalil</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Afif, Mohamed" sort="Afif, Mohamed" uniqKey="Afif M" first="Mohamed" last="Afif">Mohamed Afif</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Lachgar, Amine" sort="Lachgar, Amine" uniqKey="Lachgar A" first="Amine" last="Lachgar">Amine Lachgar</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="El Kacemi, Hanan" sort="El Kacemi, Hanan" uniqKey="El Kacemi H" first="Hanan" last="El Kacemi">Hanan El Kacemi</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Kebdani, Tayeb" sort="Kebdani, Tayeb" uniqKey="Kebdani T" first="Tayeb" last="Kebdani">Tayeb Kebdani</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Benjaafar, Noureddine" sort="Benjaafar, Noureddine" uniqKey="Benjaafar N" first="Noureddine" last="Benjaafar">Noureddine Benjaafar</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author></analytic><series><title level="j">International journal of radiation oncology, biology, physics</title><idno type="eISSN">1879-355X</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Antineoplastic Agents (therapeutic use)</term><term>Antineoplastic Agents, Hormonal (therapeutic use)</term><term>Breast</term><term>Breast Neoplasms (pathology)</term><term>Breast Neoplasms (radiotherapy)</term><term>Breast Neoplasms (surgery)</term><term>Disease-Free Survival</term><term>Dose Hypofractionation</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Hyperpigmentation (etiology)</term><term>Lymphatic Irradiation (adverse effects)</term><term>Lymphatic Irradiation (methods)</term><term>Lymphatic Metastasis</term><term>Mastectomy, Segmental</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local</term><term>Prognosis</term><term>Receptor, ErbB-2 (antagonists & inhibitors)</term><term>Retrospective Studies</term><term>Telangiectasis (etiology)</term><term>Thorax</term><term>Time Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Antinéoplasiques (usage thérapeutique)</term><term>Antinéoplasiques hormonaux (usage thérapeutique)</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Hyperpigmentation (étiologie)</term><term>Hypofractionnement de dose</term><term>Irradiation ganglionnaire ()</term><term>Irradiation ganglionnaire (effets indésirables)</term><term>Mastectomie partielle</term><term>Métastase lymphatique</term><term>Pronostic</term><term>Récepteur ErbB-2 (antagonistes et inhibiteurs)</term><term>Récidive tumorale locale</term><term>Région mammaire</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Survie sans rechute</term><term>Thorax</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (anatomopathologie)</term><term>Tumeurs du sein (radiothérapie)</term><term>Télangiectasie (étiologie)</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Receptor, ErbB-2</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents</term><term>Antineoplastic Agents, Hormonal</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymphatic Irradiation</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Récepteur ErbB-2</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Irradiation ganglionnaire</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hyperpigmentation</term><term>Telangiectasis</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymphatic Irradiation</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antinéoplasiques</term><term>Antinéoplasiques hormonaux</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Hyperpigmentation</term><term>Télangiectasie</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Breast</term><term>Disease-Free Survival</term><term>Dose Hypofractionation</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymphatic Metastasis</term><term>Mastectomy, Segmental</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local</term><term>Prognosis</term><term>Retrospective Studies</term><term>Thorax</term><term>Time Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Hypofractionnement de dose</term><term>Irradiation ganglionnaire</term><term>Mastectomie partielle</term><term>Métastase lymphatique</term><term>Pronostic</term><term>Récidive tumorale locale</term><term>Région mammaire</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Survie sans rechute</term><term>Thorax</term><term>Tumeurs du sein</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To evaluate the effect of hypofractionated radiation therapy (HFRT) of the breast/chest wall and regional nodes on overall survival (OS), disease-free survival (DFS), locoregional control and on treatment-related toxicity in patients with breast cancer and nodal involvement.</div></front></TEI><affiliations><list><country><li>Maroc</li></country><region><li>Rabat-Salé-Kénitra</li></region><settlement><li>Rabat</li></settlement></list><tree><country name="Maroc"><region name="Rabat-Salé-Kénitra"><name sortKey="Bellefqih, Sara" sort="Bellefqih, Sara" uniqKey="Bellefqih S" first="Sara" last="Bellefqih">Sara Bellefqih</name></region><name sortKey="Aarab, Jihan" sort="Aarab, Jihan" uniqKey="Aarab J" first="Jihan" last="Aarab">Jihan Aarab</name><name sortKey="Afif, Mohamed" sort="Afif, Mohamed" uniqKey="Afif M" first="Mohamed" last="Afif">Mohamed Afif</name><name sortKey="Benjaafar, Noureddine" sort="Benjaafar, Noureddine" uniqKey="Benjaafar N" first="Noureddine" last="Benjaafar">Noureddine Benjaafar</name><name sortKey="El Kacemi, Hanan" sort="El Kacemi, Hanan" uniqKey="El Kacemi H" first="Hanan" last="El Kacemi">Hanan El Kacemi</name><name sortKey="Elmajjaoui, Sanaa" sort="Elmajjaoui, Sanaa" uniqKey="Elmajjaoui S" first="Sanaa" last="Elmajjaoui">Sanaa Elmajjaoui</name><name sortKey="Kebdani, Tayeb" sort="Kebdani, Tayeb" uniqKey="Kebdani T" first="Tayeb" last="Kebdani">Tayeb Kebdani</name><name sortKey="Khalil, Jihane" sort="Khalil, Jihane" uniqKey="Khalil J" first="Jihane" last="Khalil">Jihane Khalil</name><name sortKey="Lachgar, Amine" sort="Lachgar, Amine" uniqKey="Lachgar A" first="Amine" last="Lachgar">Amine Lachgar</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000510 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000510 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28126305
|texte= Hypofractionated Regional Nodal Irradiation for Women With Node-Positive Breast Cancer.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28126305" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |